The TandemHeart®, percutaneous transseptal left ventricular assist device: a safeguard in high-risk percutaneous coronary interventions. The six-year Rotterdam experience

EuroIntervention

Volumn 4, Issue 3, 2008, Pages 331-337

  Vranckx, Pascal ^a,b   Meliga, Emanuele ^c,d   De Jaegere, Peter P T ^d   Van den Ent, Martin ^d   Regar, Evelyn S ^d   Serruys, Patrick W ^d  

^a VIRGA JESSE HOSPITAL   (Belgium)

^b CARDIALYSIS   (Netherlands)

^c UNIVERSITY OF TURIN   (Italy)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Angioplasty; Heart assist device; TandemHeart

Indexed keywords

ADULT; AGED; APPLICATION SITE BLEEDING; ARTERIAL PRESSURE; ARTICLE; ASSISTED CIRCULATION; CARDIOGENIC SHOCK; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; DEATH; DEVICE SAFETY; DISEASE SEVERITY; EMERGENCY HEALTH SERVICE; FEMALE; HEART LEFT VENTRICLE FILLING; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; HYPOTHERMIA; LEG DISEASE; LUNG WEDGE PRESSURE; MALE; NETHERLANDS; PERCUTANEOUS CORONARY INTERVENTION; TEMPERATURE; BLOOD PRESSURE; CLINICAL TRIAL; ECHOCARDIOGRAPHY; ECHOGRAPHY; HEART ASSIST DEVICE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; RISK FACTOR; RISK REDUCTION; STATISTICS; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PULMONARY WEDGE PRESSURE; RISK FACTORS; RISK REDUCTION BEHAVIOR; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 59049095051     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV4I3A60     Document Type: Article

References (20)

1. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schonberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 2001; 344: 1117-1124.
2. Serruys PW, Ong AT, van Herwerden LA, Sousa JE, Jatene AD, Bonnier JJ, Schonberger JP, Buller N, Bonser R, Disco C, Backx B, Firth B, Unger F. Five year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial. J Am Coll Cardiol. 2005; 46: 575-581
3. Topol EJ, Serruys PW. Frontiers in interventional cardiology. Circulation 1998;98:1802-1820.
4. de Feyter PJ, McFadden E. Risk score for percutaneous coronary intervention: forewarned is forearmed. J Am Coll Cardiol 2003;42(10):1729-30.
5. Singh M, Lennon RJ, Holmes DR, Jr., Bell MR, Rihal CS. Correlates of procedural complications and a simple integer risk score for percutaneous coronary intervention. J Am Coll Cardiol 2002;40(3):387-93.
6. Singh M, Rihal CS, Selzer F, Kip KE, Detre K, Holmes DR. Validation of Mayo Clinic risk adjustment model for in-hospital complications after percutaneous coronary interventions, using the National Heart, Lung, and Blood Institute dynamic registry. J Am Coll Cardiol 2003;42(10):1722-8.
7. Vanagas G, Kinduris S, Buivydaite K. Assessment of validity for EuroSCORE risk stratification system. Scand Cardiovasc J 2005;39(1-2):67-70.
8. Berman M, Stamler A, Sahar G, Georghiou GP, Sharoni E, Brauner R, Medalion B, Vidne BA, Kogan A. Validation of the 2000 Bernstein-Parsonnet score versus the EuroSCORE as a prognostic tool in cardiac surgery. Ann Thorac Surg 2006;81(2):537-40.
9. Rao AK, Pratt C, Berke A, Jaffe A, Ockene I, Schreiber TL, Bell WR, Knatterud G, Robertson TL, Terrin ML. Thrombolysis in Myocardial Infarction (TIMI) Trial: phase I: hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase. J Am Col Cardiol. 1988; 11: 1-11.
10. Kawachi Y, Nakashima A, Toshima Y, Arinaga K, Kawano H. Risk stratification analysis of operative mortality in heart and thoracic aorta surgery: comparison between Parsonnet and EuroSCORE additive model. Eur J Cardiothorac Surg 2001;20(5):961-6.
11. Thiele H, Lauer B, Hambrecht R, Boudriot E, Cohen HA, Schuler G. Reversal of cardiogenic shock by percutaneous left atrial-to-femoral arterial bypass assistance. Circulation 2001;104(24):2917-22.
12. Burkhoff D, O’Neill W, Brunckhorst C, Letts D, Lasorda D, Cohen HA. Feasibility study of the use of the TandemHeart percutaneous ventricular assist device for treatment of cardiogenic shock. Catheter Cardiovasc Interv 2006;68(2):211-7.
13. Toumpoulis IK, Anagnostopoulos CE. Can EuroSCORE accurately predict long-term outcome after cardiac surgery? Nat Clin Pract Cardiovasc Med 2005;2(12):620-1.
14. Vaina S, Stefanadis C. Treatment of multi-vessel coronary artery disease. What is the optimal revascularisation approach? What do we know, what will we learn? Hellenic J Cardiol 2007;48(1):1-4.
15. DeWood MA, Notske RN, Hensley GR, et al. Intraaortic balloon counterpulsation with and without reperfusion for myocardial infarction shock. Circulation 1980;61:1105-1112.
16. Laks H, Rosenbranz ER, Buckberg GD. Surgical treatment of cardiogenic shock after myocardial infarction. Circulation 1986; 74 (suppl III): 15-22.
17. Meyns B, Stolinski J, Leunens V, et al. Left ventricular support by catheter-mounted axial flow pump reduces infarct size. J Am Coll Cardiol 2003;41:1087-1095.
18. Thiele H, Sick P, Boudriot E, Diederich KW, Hambrecht R, Niebauer J, Schuler G. Randomized comparison of intra-aortic balloon support with a percutaneous left ventricular assist device in patients with revascularized acute myocardial infarction complicated by cardiogenic shock. Eur Heart J 2005;26(13):1276-83.
19. Shawl FA, Domanski MJ, Wish MH, Davis M. Percutaneous cardiopulmonary bypass support in the catheterization laboratory: technique and complications. Am Heart J 1990;120(1):195-203.
20. Vogel RA, Shawl F, Tommaso C, O’Neill W, Overlie P, O’Toole J, Vandormael M, Topol E, Tabari KK, Vogel J and others. Initial report of the National Registry of Elective Cardiopulmonary Bypass Supported Coronary Angioplasty. J Am Coll Cardiol 1990;15(1):23-9.